Active Biotech AB (ACTI) — Strategic Asset Allocation Index
Active Biotech AB (ACTI) has a Strategic Asset Allocation Index of 48.9% as of September 2025. Strategic assets (PP&E of Skr2.20 Million plus long-term investments of Skr-) total Skr2.20 Million, measured against net assets of Skr4.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Active Biotech AB Strategic Asset Allocation Index (2000–2024)
This chart shows how Active Biotech AB's Strategic Asset Allocation Index has evolved across 25 annual periods from 2000 to 2024. As of September 2025, the index stands at 48.9%, representing strategic assets of Skr2.20 Million against net assets of Skr4.50 Million SEK. Explore ACTI cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Active Biotech AB (2000–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Active Biotech AB from 2000 to 2024, covering 25 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ACTI company net worth.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 10.5% | Skr3.35 Million | Skr3.35 Million | Skr- | Skr32.07 Million | ▼ -4.9 pp |
| 2023 | 15.4% | Skr4.72 Million | Skr4.72 Million | Skr- | Skr30.67 Million | ▼ -2.9 pp |
| 2022 | 18.3% | Skr6.30 Million | Skr6.30 Million | Skr- | Skr34.51 Million | ▲ +16.2 pp |
| 2021 | 2.0% | Skr945.00K | Skr945.00K | Skr- | Skr46.67 Million | ▼ -6.4 pp |
| 2020 | 8.5% | Skr1.87 Million | Skr1.87 Million | Skr- | Skr22.11 Million | ▲ +2.5 pp |
| 2019 | 5.9% | Skr3.19 Million | Skr3.19 Million | Skr- | Skr53.78 Million | ▲ +4.5 pp |
| 2018 | 1.4% | Skr1.27 Million | Skr1.27 Million | Skr- | Skr87.92 Million | ▼ -0.8 pp |
| 2017 | 2.2% | Skr1.71 Million | Skr1.71 Million | Skr- | Skr77.68 Million | ▼ -177.5 pp |
| 2016 | 179.7% | Skr328.07 Million | Skr328.07 Million | Skr- | Skr182.56 Million | ▼ -2.9 pp |
| 2015 | 182.6% | Skr329.80 Million | Skr329.80 Million | Skr- | Skr180.60 Million | ▲ +88.5 pp |
| 2014 | 94.2% | Skr381.64 Million | Skr381.64 Million | Skr- | Skr405.31 Million | ▲ +0.2 pp |
| 2013 | 94.0% | Skr381.03 Million | Skr381.03 Million | Skr- | Skr405.41 Million | ▼ -18.2 pp |
| 2012 | 112.2% | Skr381.50 Million | Skr381.50 Million | Skr- | Skr339.92 Million | ▲ +36.0 pp |
| 2011 | 76.2% | Skr382.66 Million | Skr382.66 Million | Skr- | Skr501.99 Million | ▼ -121.0 pp |
| 2010 | 197.2% | Skr358.51 Million | Skr358.51 Million | Skr- | Skr181.76 Million | ▲ +28.1 pp |
| 2009 | 169.1% | Skr318.99 Million | Skr318.99 Million | Skr- | Skr188.64 Million | ▼ -29.3 pp |
| 2008 | 198.4% | Skr324.55 Million | Skr324.55 Million | Skr- | Skr163.61 Million | ▲ +24.4 pp |
| 2007 | 173.9% | Skr329.70 Million | Skr329.70 Million | Skr- | Skr189.57 Million | ▼ -402.1 pp |
| 2006 | 576.1% | Skr347.70 Million | Skr347.70 Million | Skr- | Skr60.36 Million | ▲ +362.9 pp |
| 2005 | 213.2% | Skr376.90 Million | Skr376.90 Million | Skr- | Skr176.81 Million | ▲ +189.1 pp |
| 2004 | 24.1% | Skr39.06 Million | Skr39.06 Million | Skr- | Skr162.30 Million | ▲ +6.7 pp |
| 2003 | 17.4% | Skr50.30 Million | Skr50.30 Million | Skr- | Skr289.58 Million | ▲ +1.5 pp |
| 2002 | 15.8% | Skr60.20 Million | Skr60.20 Million | Skr- | Skr380.27 Million | ▲ +4.9 pp |
| 2001 | 10.9% | Skr74.26 Million | Skr74.26 Million | Skr- | Skr678.78 Million | ▼ -19.6 pp |
| 2000 | 30.6% | Skr197.45 Million | Skr197.45 Million | Skr- | Skr646.03 Million | — |